Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Ana‐Maria Vilcu, Clara Mazagatos et al.|Eurosurveillance|2021Cited by 55
2015/16 I‐<scp>MOVE</scp>/I‐<scp>MOVE</scp>+ multicentre case‐control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage‐mismatched influenza B among childrenEsther Kissling, Marta Valenciano, Francisco Pozo et al.|Influenza and Other Respiratory Viruses|2017Cited by 37
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021Esther Kissling, Mariëtte Hooiveld, Iván Martínez‐Baz et al.|Eurosurveillance|2022Cited by 27
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre study analysis by age-group, vaccine brand and time since vaccination, I-MOVE-COVID-19 and ECDC networks, July–August 2021Esther Kissling, Marta Valenciano, Mariëtte Hooiveld et al.|Unknown|2021Cited by 2